Targeting QseC Signaling and Virulence for Antibiotic Development

David A. Rasko(Brigham and Women's Hospital), Cristiano G. Moreira(Brigham and Women's Hospital), De Run Li(Brigham and Women's Hospital), Nicola C. Reading(Brigham and Women's Hospital), Jennifer M. Ritchie(Brigham and Women's Hospital), Matthew K. Waldor(Brigham and Women's Hospital), Noelle S. Williams(Brigham and Women's Hospital), Ron Taussig(Brigham and Women's Hospital), Shuguang Wei(Brigham and Women's Hospital), Michael G. Roth(Brigham and Women's Hospital), David T. Hughes(Brigham and Women's Hospital), Jason F. Huntley(Brigham and Women's Hospital), Maggy Fina(Brigham and Women's Hospital), John R. Falck(Brigham and Women's Hospital), Vanessa Sperandio(Brigham and Women's Hospital)
Science
August 21, 2008
Cited by 507

Abstract

Many bacterial pathogens rely on a conserved membrane histidine sensor kinase, QseC, to respond to host adrenergic signaling molecules and bacterial signals in order to promote the expression of virulence factors. Using a high-throughput screen, we identified a small molecule, LED209, that inhibits the binding of signals to QseC, preventing its autophosphorylation and consequently inhibiting QseC-mediated activation of virulence gene expression. LED209 is not toxic and does not inhibit pathogen growth; however, this compound markedly inhibits the virulence of several pathogens in vitro and in vivo in animals. Inhibition of signaling offers a strategy for the development of broad-spectrum antimicrobial drugs.


Related Papers

No related papers found

Powered by citation graph analysis